硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 EVL 抗体对
试剂盒

抗人 EVL 抗体对

01AB02411

Enah/Vasp-like (EVL) is a member of the Ena/VASP protein family, characterized by its modular structure comprising an EVH1 domain for membrane targeting and an EVH2 domain containing G-actin and F-actin binding sites, as well as a coiled-coil motif essential for tetramerization and actin filament bundling. EVL localizes to the leading edge of lamellipodia and filopodial tips, where it regulates actin dynamics by promoting actin polymerization and inhibiting filament capping, thereby facilitating cellular processes such as shape change, adhesion, migration, and cell-cell interaction. The EVH2 domain is crucial for actin binding and polymerization, with specific motifs mediating interactions with actin monomers and filaments, and phosphorylation sites modulating its activity. Dysregulation of EVL and related Ena/VASP proteins has been implicated in diseases including thrombosis, cancer, arteriosclerosis, cardiomyopathy, and nephritis, highlighting their significance in both cellular homeostasis and pathology.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
EVL
基因别名
RNB6
蛋白别名
Enah/Vasp-like; EVL
UniProt
Q9UI08
物种
Human

产品详情

靶点名称
EVL
蛋白名称
Enah/Vasp-like
蛋白别名
Ena/VASP-like protein; Ena/vasodilator-stimulated phosphoprotein-like
靶点基因名
EVL
基因别名
RNB6
UniProt
Q9UI08
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Enah/Vasp-like (EVL) is a member of the Ena/VASP protein family, characterized by its modular structure comprising an EVH1 domain for membrane targeting and an EVH2 domain containing G-actin and F-actin binding sites, as well as a coiled-coil motif essential for tetramerization and actin filament bundling. EVL localizes to the leading edge of lamellipodia and filopodial tips, where it regulates actin dynamics by promoting actin polymerization and inhibiting filament capping, thereby facilitating cellular processes such as shape change, adhesion, migration, and cell-cell interaction. The EVH2 domain is crucial for actin binding and polymerization, with specific motifs mediating interactions with actin monomers and filaments, and phosphorylation sites modulating its activity. Dysregulation of EVL and related Ena/VASP proteins has been implicated in diseases including thrombosis, cancer, arteriosclerosis, cardiomyopathy, and nephritis, highlighting their significance in both cellular homeostasis and pathology.